Award
NIH Reporter #11196088
Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids
Recipient
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Award Amount
$3,172,763.00
Ceiling
$3,172,763.00
Awarded
September 05, 2025
Identifier
11196088
Research project funded by the National Institute on Drug Abuse to evaluate psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids.
Description
The project involves research on psilocybin as a treatment for opioid use disorder. The study will recruit participants from opioid treatment programs in New York and New Mexico. The project uses an adaptive design with multiple phases and aims to provide evidence for FDA approval of psilocybin for this indication.